Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
San Francisco, United States
Countries of investment
  • USA
  • China
  • Hong Kong
Investment stages
  • Pre-Seed
  • Seed
  • Series A
  • Series B
  • Series C
Industries
  • Health Tech
  • Biotechnology
  • AI
  • Fintech
About
Pivotal Life Sciences is a leading venture capital firm dedicated to funding innovative companies that are pioneering therapeutic solutions for significant unmet medical needs. Established in 2017, we leverage our deep industry expertise to identify and support transformative therapeutic advancements that can improve patient outcomes. Our strategic investment approach focuses on fostering growth in the life sciences sector, ensuring that breakthrough therapies reach the market while enhancing the overall healthcare landscape. Through our commitment to innovation and excellence, Pivotal Life Sciences aims to be a catalyst for change in the medical field.
Min check size
$1M
Max check size
$10M
Fund size
NPS

Investment Thesis

Pivotal Life Sciences is a global healthcare investment firm that supports companies developing high impact therapeutics to address major unmet medical needs. Their strategy is to invest in companies at all stages, with a primary focus on high impact therapeutics—solutions that address growing unmet medical needs and have nearcurative or transformative disease management potential. Pivotal Life Sciences aims to partner with scientists and entrepreneurs to support company building and derisking value inflection points.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

With a robust background in venture capital, the fund manager has actively engaged in over 30 deals across technology and healthcare sectors, primarily in North America. Their strategic approach emphasizes an operator-first mentality, leveraging deep industry insights to drive growth in early-stage companies. Noteworthy exits include successful partnerships that have yielded significant returns, demonstrating a strong track record in identifying and nurturing high-potential investments. The manager's data-driven strategies are complemented by a commitment to thematic investing, focusing on innovation and sustainability.

Pivotal Life Sciences Contacts Information

Primary contact

Secondary contact

Team

Vincent Cheung

Vincent Cheung

Jim Trenkle

David Malek

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp